Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
This is a Phase III, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of escitalopram (30 mg/day) in two parallel groups (randomization ratio, escitalopram 2/placebo 1).
Inclusion criteria
- pulmonary hypertension